AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 15 filers reported holding AKARI THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $12,000 | -14.3% | 11,532 | -3.9% | 0.00% | – |
| Q1 2022 | $14,000 | -22.2% | 12,000 | 0.0% | 0.00% | – |
| Q4 2021 | $18,000 | -10.0% | 12,000 | 0.0% | 0.00% | – |
| Q3 2021 | $20,000 | -4.8% | 12,000 | 0.0% | 0.00% | – |
| Q2 2021 | $21,000 | -34.4% | 12,000 | 0.0% | 0.00% | – |
| Q1 2021 | $32,000 | +45.5% | 12,000 | 0.0% | 0.00% | – |
| Q4 2020 | $22,000 | +4.8% | 12,000 | 0.0% | 0.00% | – |
| Q3 2020 | $21,000 | -19.2% | 12,000 | 0.0% | 0.00% | – |
| Q2 2020 | $26,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 178,091 | $703,459 | 0.52% |